Veracyte (VCYT) just packed a lot into one session. Fresh third quarter results, a slight trim to full year revenue guidance, and a US$100 million buyback authorization all hit at once. The short-term...
Source LinkVeracyte (VCYT) just packed a lot into one session. Fresh third quarter results, a slight trim to full year revenue guidance, and a US$100 million buyback authorization all hit at once. The short-term...
Source Link
Comments